Myelofibrosis: FDA Approved Treatment Options and Updates from ASH 2023
Overview of the current FDA approved treatment options for the management of myelofibrosis as well as reviewing recent updates from ASH 2023 on the SIMPLIFY and PERSIST trials.
EP: 1.Diagnosing Polycythemia Vera (PV)
EP: 2.Polycythemia Vera: Assessing Risk and Genetic Testing
EP: 3.Polycythemia Vera: Treatment Goals and Options
EP: 4.REVEAL Study: Clinical Implications
EP: 5.Polycythemia Vera: Choosing the Right Treatment
EP: 6.MAJIC-PV: Clinical Implications in PV
EP: 7.Role of Transplant in Myelofibrosis
Now Viewing
EP: 8.Myelofibrosis: FDA Approved Treatment Options and Updates from ASH 2023
EP: 9.Treating Patients with Myelofibrosis and Anemia
EP: 10.Monitoring Patients on Myelofibrosis Treatment
EP: 11.Future of PV: Unmet Needs
EP: 12.Combination Therapies for MF Management
EP: 13.Future of MF
Related Videos
Related Content
